Anti-cancer agents (Vinblastine, Vincristine, Taxol)
Start with the big picture
Vinblastine and vincristine are indole-dihydroindole vinca alkaloids from Catharanthus roseus; paclitaxel (Taxol) is a taxane diterpene originally obtained from Taxus brevifolia and produced at scale through semisynthesis. These M-phase-specific agents interfere with microtubules in different ways: vincas bind β-tubulin and inhibit polymerization, whereas paclitaxel binds a distinct site and prevents depolymerization. Both pathways can lead to mitotic arrest and apoptosis. Their clinical roles differ, as do their dose-limiting toxicities: neuropathy and ileus are prominent concerns with vincristine, myelosuppression with vinblastine, and myelosuppression with possible sensory neuropathy with paclitaxel. Safe use also depends on administration precautions, interaction awareness, and appropriate handling.
What you'll learn
- Identify the plant sources and chemical classes of the vinca alkaloids and paclitaxel.
- Compare how vinca alkaloids and paclitaxel alter microtubule dynamics.
- Relate mitotic arrest to apoptosis in these anticancer agents.
- Recognize representative clinical indications and dose-limiting toxicities for each agent.
- Describe important administration, interaction, and handling precautions.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
